ArticlePeerJ2023

Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.